Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage
Condition(s):Prostate Cancer; Castrate Resistant Prostate CancerLast Updated:February 28, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Prostate Cancer; Castrate Resistant Prostate CancerLast Updated:February 28, 2024Recruiting
Condition(s):Prostate CancerLast Updated:September 4, 2018Completed
Condition(s):Advanced Prostate Adenocarcinoma; Stage III Prostate Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8Last Updated:December 15, 2023Recruiting
Condition(s):Prostatic NeoplasmsLast Updated:December 20, 2023Active, not recruiting
Condition(s):Prostatic AdenocarcinomaLast Updated:August 29, 2023Not yet recruiting
Condition(s):Prostate Cancer MetastaticLast Updated:December 22, 2023Recruiting
Condition(s):Metastatic Prostate Cancer; Prostate AdenocarcinomaLast Updated:July 17, 2023Active, not recruiting
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:March 28, 2023Active, not recruiting
Condition(s):High-risk Prostate Cancer; Neoadjuvant TherapyLast Updated:December 8, 2023Active, not recruiting
Condition(s):Arrhythmias, Cardiac; Atrial Fibrillation and Flutter; Tachycardia, Supraventricular; Cardiac FailureLast Updated:October 18, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.